Status:
RECRUITING
Dongzong Cardiovascular Bio-imaging Registry Study
Lead Sponsor:
Jinling Hospital, China
Conditions:
Cardiovascular Diseases
Multi-omics
Eligibility:
All Genders
18+ years
Brief Summary
The DAILY project is a large-scale, multicenter, prospective initiative designed to establish a comprehensive bio-imaging database that integrates multidimensional data, including living environments,...
Detailed Description
Cardiovascular diseases (CVD) are the leading cause of global mortality, representing a major public health challenge that threatens life and health both presently and in the foreseeable future. The r...
Eligibility Criteria
Inclusion
- Aged ≥18 years
- Coronary CT angiography performed
- Informed consent acquired
Exclusion
- Unable to complete the follow-up
- Serious chronic kidney disease (eGFR\< 30 ml/min/1.73 m2)
- Serious liver disease or dysfunction (chronic active hepatitis and cirrhosis, or aspartate aminotransferase (AST) or alanine transaminase (ALT) \> 3 times the upper limit of normal)
- Not appropriate to be tested due to birth planning, allergies, acute thyroid storm, etc.
- Suspected or known infectious diseases, such as hepatitis B virus (HBV), human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), and Treponema pallidum (syphilis), etc.
Key Trial Info
Start Date :
May 24 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2038
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT06894095
Start Date
May 24 2023
End Date
May 31 2038
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Longjiang Zhang
Nanjing, Jiangsu, China, 210002